Becton, Dickinson and (BDX) Stock: Buy, Sell, or Hold?
BDX - Becton, Dickinson and Co.
$178.79
-0.22 (-0.12%)
▼
5d:
-0.25%
30d:
-4.45%
90d:
+13.1%
HOLD
MODERATE Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When BDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BDX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: BDX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$205.20
Based on 4.7% avg growth
INTRINSIC VALUE TODAY
$127.42
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BDX is currently trading at $178.78, which is considered oversold relative to its 30-day fair value range of $179.78 to $187.90. The stock's valuation (Forward PE: 13.5) is in line with its historical norms (12.3). At these levels, the market is pricing in 3.0% annual earnings growth.
Technical Outlook: Technically, BDX is in a strong uptrend. The price is currently testing key support at $177.02. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BDX is in a strong uptrend. The price is currently testing key support at $177.02. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$179.78 -
$187.90
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.1%
Protect Your Profits
Holding BDX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (42/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($195.67)
- BULLISH: Expecting earnings turnaround to 3.0% growth with 5.4% revenue growth
- NEUTRAL: Bottoming setup forming (42/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$179.78 -
$187.90
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$177.02
Resistance Level
$184.37
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.47
Wall Street Target
$195.67
(+9.3%)
Revenue Growth (YoY)
5.4%
Earnings Growth (YoY)
-31.4%
Profit Margin
4.2%
Valuation Premium vs History
+3.0% premium
PE vs Historical
13.5 vs 12.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.0%
(market-implied from PE analysis)
1-Year Target
$184.37
(+3%)
2-Year Target
$189.90
(+6%)
3-Year Target
$195.60
(+9%)
3-Yr Target (if PE normalizes)
(PE: 13→12)
PE COMPRESSION
$178.66
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 5.3%)
$316.65
(+77%)
Base:
(SPY PE: 13.5, Growth: 5.3%)
$209.02
(+17%)
Bear:
(PE: 11.4, Growth: 5.3%)
$177.67
(-1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (32x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 31.87 | Current EPS (TTM): $5.71
Bull Case
$400.33
(+124%)
Analyst growth 100.0%, PE expands to 35.1
Base Case
$363.94
(+103%)
Market implied 100.0%, PE stable at 31.9
Bear Case
$123.74
(-31%)
Severe decline -20.0%, PE contracts to 27.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 01, 2026 3:34 PM ET
Data refreshes hourly during market hours. Next update: 4:34 PM
Data refreshes hourly during market hours. Next update: 4:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$84 | 50 HOLD |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$476 | 33 SELL |
|
RMD
ResMed Inc |
BUY
19 analysts |
$250 | 62 BUY |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$66 | 58 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$408 | 52 HOLD |
Advanced BDX Option Strategies
Professional options setups generated by AI based on today's BDX price and gamma walls.
